Lantern Pharma (LTRN) Institutional Ownership $3.34 -0.14 (-4.02%) Closing price 05/21/2025 04:00 PM EasternExtended Trading$3.32 -0.02 (-0.75%) As of 05/21/2025 05:21 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Lantern Pharma (NASDAQ:LTRN)CurrentInstitutional OwnershipPercentage28.62%Number ofInstitutional Buyers(last 12 months)8TotalInstitutional Inflows(last 12 months)$4.49MNumber ofInstitutional Sellers(last 12 months)4TotalInstitutional Outflows(last 12 months)$441.61K Get LTRN Insider Trade Alerts Want to know when executives and insiders are buying or selling Lantern Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data LTRN Institutional Buying and Selling by Quarter Lantern Pharma Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/16/2025 NewEdge Advisors LLC59,924$212K0.0%-12.3%0.556% 4/23/2025 Perigon Wealth Management LLC39,387$139K0.0%+169.8%0.365% 2/17/2025 Two Sigma Investments LP16,545$53K0.0%-51.8%0.153% 2/14/2025 Voss Capital LP50,000$160K0.0%N/A0.464% 2/13/2025 NewEdge Advisors LLC68,359$218K0.0%-50.2%0.634% 2/13/2025 Renaissance Technologies LLC87,300$278K0.0%+3.9%0.810% 2/10/2025 BIOS Capital Management LP1,207,709$3.85M4.1%N/A11.203% 2/7/2025 CM Management LLC200,000$638K0.6%+8.1%1.855% 1/31/2025Sanctuary Advisors LLC10,000$32K0.0%N/A0.093% 1/24/2025 DAVENPORT & Co LLC25,814$82K0.0%-52.0%0.239% Get the Latest News and Ratings for LTRN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Lantern Pharma and its competitors with MarketBeat's FREE daily newsletter. 1/22/2025 Perigon Wealth Management LLC14,600$47K0.0%-49.5%0.135% 11/20/2024 Westside Investment Management Inc.30,650$112K0.0%+166.5%0.284% 8/9/2024 Renaissance Technologies LLC81,800$382K0.0%+24.5%0.760% 8/9/2024 Dimensional Fund Advisors LP18,413$86K0.0%+55.7%0.171% 8/2/2024 CM Management LLC80,000$374K0.3%+23.1%0.743% 7/17/2024 Westside Investment Management Inc.11,500$54K0.0%N/A0.107% 5/14/2024 CM Management LLC65,000$572K0.5%-18.8%0.604% 5/10/2024 Tocqueville Asset Management L.P.19,000$167K0.0%N/A0.177% 4/10/2024 Pathway Financial Advisors LLC25,001$220K0.1%-12.3%0.233% 2/12/2024 Redmond Asset Management LLC40,662$174K0.1%-12.6%0.374% 2/8/2024 Meridian Wealth Management LLC19,660$84K0.0%+18.0%0.181% 2/1/2024 Sigma Planning Corp11,875$51K0.0%-34.5%0.109% 2/1/2024 Pathway Financial Advisors LLC28,501$122K0.0%-13.0%0.262% 10/30/2023 Pathway Financial Advisors LLC32,771$112K0.0%+134.1%0.302% 10/17/2023 Meridian Wealth Management LLC16,660$57K0.0%N/A0.153% 8/10/2023 Carlson Capital L P95,000$536K0.0%-23.9%0.875% 8/4/2023 CM Management LLC75,000$423K0.4%+25.0%0.691% 7/19/2023 Pathway Financial Advisors LLC14,001$79K0.0%N/A0.129% 2/9/2023 CM Management LLC60,000$362K0.4%+20.0%0.552% 2/9/2023 Wolff Wiese Magana LLC27,098$164K0.1%-11.0%0.250% 2/7/2023Lynwood Capital Management Inc.12,000$73K0.1%N/A0.110% 11/15/2022 Carlson Capital L P168,000$803K0.1%-1.2%1.547% 11/4/2022 CM Management LLC50,000$239K0.3%+10.9%0.462% 8/8/2022 CM Management LLC45,100$258K0.3%+33.6%0.416% 7/15/2022 Wolff Wiese Magana LLC31,575$180K0.1%-12.7%0.292% 7/11/2022 Sanders Morris Harris LLC366,030$2.06M0.5%-4.7%3.379% 5/9/2022 CM Management LLC33,765$241K0.2%N/A0.312% 5/9/2022 Wolff Wiese Magana LLC36,155$259K0.2%+5.9%0.334% 4/11/2022 Sanders Morris Harris LLC384,228$2.75M0.5%+14.2%3.564% 2/4/2022 Envestnet Asset Management Inc.10,542$84K0.0%N/A0.094% Trump + Musk = AI’s turning point (Ad)Trump may not code… but he knows how to pick winners. And according to insiders, his administration is preparing to fast-track a new class of AI infrastructure tech. Elon Musk has already poured $51 million into it.Chris Rowe just shared the full details in a live presentation… Watch it here before it comes down.2/4/2022 Redmond Asset Management LLC49,187$393K0.1%+3.7%0.440% 2/3/2022 Advisor Group Holdings Inc.5,331$43K0.0%+92.5%0.048% 2/2/2022 Sanders Morris Harris LLC336,425$2.57M0.4%N/A3.007% 2/2/2022 Sigma Planning Corp17,600$140K0.0%N/A0.157% 1/14/2022 Spire Wealth Management4,050$32K0.0%+285.7%0.036% 11/9/2021BlackRock Inc.23,074$258K0.0%-8.1%0.206% 11/5/2021 Advisor Group Holdings Inc.2,770$31K0.0%+177.0%0.025% 11/2/2021Raymond James & Associates25,879$289K0.0%N/A0.231% 10/29/2021 GWM Advisors LLC155,859$1.74M0.0%+3.0%1.394% 10/22/2021 Redmond Asset Management LLC47,442$530K0.2%+4.3%0.424% 10/15/2021 Wolff Wiese Magana LLC35,316$395K0.3%+24.7%0.316% 8/16/2021Corriente Advisors LLC656,364$9.58M5.2%-8.0%5.869% 8/13/2021 Geode Capital Management LLC55,479$809K0.0%+21.1%0.496% 8/13/2021 Vanguard Group Inc.269,429$3.93M0.0%+4.0%2.409% 8/11/2021 Bank of New York Mellon Corp26,765$391K0.0%+127.3%0.239% 7/31/2021 GWM Advisors LLC151,316$2.21M0.1%N/A1.353% 5/21/2021 Citadel Advisors LLC11,192$203K0.0%N/A0.100% 5/18/2021 Millennium Management LLC42,106$764K0.0%N/A0.377% 5/18/2021 Morgan Stanley50,702$920K0.0%+81.6%0.453% 5/18/2021Corriente Advisors LLC713,806$12.95M4.8%N/A6.384% 5/18/2021 Citadel Advisors LLC11,192$203K0.0%N/A0.100% 5/13/2021 Bank of New York Mellon Corp11,775$213K0.0%N/A0.105% 5/12/2021 Northern Trust Corp12,629$229K0.0%N/A0.113% 5/12/2021 Geode Capital Management LLC45,830$831K0.0%N/A0.410% 5/12/2021 UBS Group AG2,166$39K0.0%N/A0.019% 5/7/2021BlackRock Inc.23,650$429K0.0%+351.2%0.212% 4/28/2021 US Bancorp DE2,000$36K0.0%N/A0.018% (Data available from 1/1/2016 forward) LTRN Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of LTRN shares? During the previous two years, 17 institutional investors and hedge funds held shares of Lantern Pharma. The most heavily invested institutionals were BIOS Capital Management LP ($3.85M), CM Management LLC ($638K), Carlson Capital L P ($536K), Renaissance Technologies LLC ($278K), Pathway Financial Advisors LLC ($220K), NewEdge Advisors LLC ($212K), and Redmond Asset Management LLC ($174K).Learn more on LTRN's institutional investors. What percentage of Lantern Pharma stock is owned by institutional investors? 28.62% of Lantern Pharma stock is owned by institutional investors. Learn more on LTRN's institutional investor holdings. Which institutional investors have been buying Lantern Pharma stock? Of the 11 institutional investors that purchased Lantern Pharma stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: BIOS Capital Management LP ($1.21M), Voss Capital LP ($50K), CM Management LLC ($45K), Pathway Financial Advisors LLC ($32.77K), Westside Investment Management Inc. ($30.65K), Perigon Wealth Management LLC ($24.79K), and Meridian Wealth Management LLC ($19.66K). How much institutional buying is happening at Lantern Pharma? Institutional investors have bought a total of 1,465,562 shares in the last 24 months. This purchase volume represents approximately $4.95M in transactions. Which Lantern Pharma major shareholders have been selling company stock? Of the 9 institutional investors that sold Lantern Pharma stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: NewEdge Advisors LLC ($77.41K), Carlson Capital L P ($29.90K), DAVENPORT & Co LLC ($28K), Two Sigma Investments LP ($17.80K), CM Management LLC ($15K), Perigon Wealth Management LLC ($14.30K), and Pathway Financial Advisors LLC ($7.77K). How much institutional selling is happening at Lantern Pharma? Institutional investors have sold a total of 202,273 shares in the last 24 months. This volume of shares sold represents approximately $843.08K in transactions. Related Companies PRME Major Shareholders INMB Major Shareholders TLSA Major Shareholders MOLN Major Shareholders ELDN Major Shareholders OGI Major Shareholders INBX Major Shareholders PRQR Major Shareholders HURA Major Shareholders DMAC Major Shareholders This page (NASDAQ:LTRN) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredWarning: Prepare to Be Shocked by These PayoutsThere's a strategy out there paying up to 70% on tech stocks like Amazon, Tesla, and Microsoft—stocks that don...Investors Alley | SponsoredThe Prophet's Newest PredictionA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredA new financial chapter Porter Stansberry says what happened last week could become the defining legacy of his financial publishing ca...Porter & Company | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s Bitcoin Reserve is No Accident…How everyday investors are building crypto wealth (step-by-step guide) Don't wait. The window for maximum g...Crypto 101 Media | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredSilver Is the New Oil—And the World’s Running DryElon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lantern Pharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lantern Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
